key: cord-0016525-02cwdkcn
authors: Bradshaw, Ralph A.; Stahl, Philip D.
title: Starting over and thinking long term…
date: 2021-03-25
journal: FASEB Bioadv
DOI: 10.1096/fba.2021-00031
sha: fa9b632856610e76686509f43cec07d998e4b724
doc_id: 16525
cord_uid: 02cwdkcn

nan

Although the long-awaited arrival of 2021 has come and gone, it has already become symbolic of new (and generally very much better) times. Although it is undoubtedly going to share some of the COVID-19 misery/disruption with its predecessor, it also promises to be the year we see it dismissed. Sadly, picking up the pieces will extend far beyond it.

About a half year ago, when the pandemic was in its infancy, we opined on the rapid therapeutic/diagnostic/prophylactic responses of the scientific community (public and private) (favorably), the level of global cooperation among scientists (also favorably), and the already lackluster responses of world leadership to the magnitude of the threat (not so favorably). 1 The good and the bad of what followed is illustrated by the creation, production and administration of effective vaccines before the end of 2020-an unparalleled scientific accomplishment/landmark in the history of human science endeavors-while, in contrast, the rollout of mass vaccination programs, a decidedly political enterprise, has been fraught with inefficiency and inadequacies that have unnecessarily delayed protecting vulnerable people in our societies. This makes the looming challenge of more threatening variants of the SARS-2 coronavirus that have already appeared even more concerning. Vaccine developers may well be able to make changes in the vaccines, if needed, to deal with mutant viruses, but will they be effectively distributed to the public?

Taken as a whole, the management of the COVID experience so far demonstrates in all too vivid a manner the necessity of supporting science, learning the lessons from past experiences that scientific knowledge can provide, and, finally, forging responses that utilize this information in the best way possible. We noted in our previous piece that the so-called Spanish Flu pandemic of 1918-1919 indeed provided important information, even though it was much less well understood at the molecular level than COVID-19, and importantly warned that the appearance of a new pandemic was only a matter of time. This advice was roundly ignored and the preparedness that could have been done was not.

Regardless of how it has been managed, the pandemic has had overwhelming impact on every aspect of our lives, whether one was infected or not. Perhaps the hardest thing to reconcile is that for most of us it has been time lost (that of course will never return) along with the accomplishments, experiences and memories that would have normally gone with it. And, of course, there will be consequences of the responses that were, often hastily, introduced to comply with the necessities of limiting social interactions. However, this may not be all bad, as in at least some cases these modifications have spawned new approaches. FASEB BioAdvances created two special collections on medical school education 2,3 that explore various aspects of pandemic-inspired alterations in teaching and curriculum design and will, in the long haul, assess which of the modifications introduced will likely become a permanent part of the teaching repertoire. It has also recently published an in-depth review of scientific meeting formats by the leadership of the Keystone Symposia in Molecular and Cellular Biology that discusses how the hiatus in face-to-face meetings, the creation of virtual meetings, and the emergence of hybrid meetings will likely impact the future of scientific conferences. 4 While the pandemic can hardly be ignored or minimized, it is not the only issue that confronts society and the scientific community. This could not be better illustrated than by the letter from then President-elect Biden to Prof. Eric Lander, of the Broad Institute, as his nominee for presidential science advisor and head of the Office of Science and Technology Policy (OSTP). 5 In it he lays out five tasks (challenges) and notes, My hope is that you, working broadly and transparently with the diverse scientific leadership of American society and engaging the broader American public, will make recommendations to our administration on the general strategies, specific actions, and new structures that the federal government should adopt to ensure that our nation can continue to harness the full power of science and technology on behalf of the American people.

He goes on to identify these areas: the pandemic, climate change, maintaining US leadership in science, diversity (and the more uniform benefit to all from scientific advancement), and the long-term viability/productivity of the American scientific community. Collectively and individually, these represent issues of central importance and ones that have suffered during the previous administration. Indeed, it can be argued that the past four years were only the end point of a greater anti-intellectual slide that has manifested in American society despite the enormous advances in science and technology since the Second World War. This is fresh air for the scientific community and a welcome entreaty to everyone interested in seeing science play its most effective role in making the world a better and safer place. This should be endorsed and embraced.

With the change in administrations on January 20 of this year, there are many more alterations looming that also auger well for the return of science, harkened by the Biden Administration's approach to these issues, including elevating the head of OSTP to a cabinet-level appointment and the selection of Prof. Alondra Nelson of the University of California San Diego as deputy director for science and society, which promises that his administration will seriously address issues of racism and diversity in the scientific community. Many thoughts have already been expressed about reinserting science into its rightful place-providing society and its leaders with the best possible facts germane to any given situation to enable the best possible decisions to be made. In an article published in Scientific American in February 2021, 6 Jane Lubchenco, Distinguished University Professor at Oregon State University and former administrator of the National Oceanic and Atmospheric Administration, points out four ways the Biden administration can help to bring this around: make science and scientists prominent (again?); restore and strengthen the conditions that enable science to thrive and inform decisions; modernize the use of science across the agencies; and depoliticize scienceit is not partisan. This last point seems so very important. One of us (RAB) has spent quite a lot of time over the years as part of FASEB or other learned societies advocating on Capitol Hill for biomedical research funding, a significant part of the government's involvement in science. One of the most rewarding parts of this discourse was the genuine interest of members of both political parties who recognized that medical research and science were done for the greater good and the impact of its successes was important to all Americans, to say nothing of people of other countries. There has been some slippage in what the norm was, and it is a place that our congressional leaders need to be reeducated.

Overall, this list is not asking for anything particularly unusual or inappropriate. Having to restore science/scientists to a respected position, provide it/them with the updated tools needed and recognize that health, the environment, etc. are universal/nonpolitical issues is a sorry statement reflecting the anti-intellectualism that has continued to unfold here and elsewhere. Unlike America, which we do not need to make "great again" because it already is, we do need to make science relevant again. We should all do what we can to help the Biden Administration achieve this.

Ralph A. Bradshaw 1 Philip D. Stahl 2

On pandemics, pandemonium, and possibilities

(ISSN)2573-9832.biome dical -educa tion 3. Managing medical curricula in the pandemic

Are in-person scientific conferences dead or alive? FASEB BioAdv

Biden should restore the role of science in the U.S. government: four ways the new administration can elevate evidence and build up the science ranks